DB
ROIVW

Dmitry Balyasny’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Dmitry Balyasny’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-150,000
Closed -$59K – 3369
2022
Q3 		$59K Hold
150,000
– – ﹤0.01% 2458
2022
Q2 		$90K Hold
150,000
– – ﹤0.01% 2293
2022
Q1 		$132K Hold
150,000
– – ﹤0.01% 2101
2021
Q4 		$305K Buy
+150,000
New +$229K ﹤0.01% 1739

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Dmitry Balyasny's ROIVW Position: Q4 2022 in Review

Dmitry Balyasny sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q4 2022, closing a stake of 150,000 shares — an estimated $59K sold.

Dmitry Balyasny first reported a position in ROIVW in Q4 2021 and held it in 4 quarters. The position peaked at $305K in Q4 2021. 28 funds tracked by Wall St. Rank hold ROIVW as of Q4 2022.

  • Dmitry Balyasny reported no remaining Roivant Sciences Ltd. Warrant position as of Q4 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 150,000 Roivant Sciences Ltd. Warrant shares in Q4 2022, an estimated $59K.
  • Dmitry Balyasny first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 4 quarters.
  • Dmitry Balyasny's Roivant Sciences Ltd. Warrant position peaked at $305K in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.